Literature DB >> 17062176

How much does heterosexual commercial sex contribute to India's HIV epidemic?

David Gisselquist1, Mariette Correa.   

Abstract

Through a search, we identified five models of India's HIV epidemic, all of which articulate the hypothesis that heterosexual commercial sex drives India's HIV epidemic. All five models assume more female sex workers (FSWs) than have been mapped (counted), and more than can be inferred from men's sexual behaviour. With best and highest plausible evidence-based estimates (15-20% of 300,000-700,000 FSWs are HIV-positive; FSWs have 570 client contacts per year; clients use condoms with 60-75% of FSW contacts; and the rate of HIV transmission from FSWs to clients is 0.0011-0.002 per unprotected contact), FSWs and clients account for 2-15% of HIV-infected adults, far less than model-based estimates of 44-68%. Overestimating the contribution of commercial sex to India's HIV epidemic misleads prevention programmes to ignore other risks, and promotes the stigmatizing assumption that HIV infection is a sign of immoral behaviour.

Entities:  

Mesh:

Year:  2006        PMID: 17062176     DOI: 10.1258/095646206778691022

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  3 in total

1.  Associations of sex trafficking history with recent sexual risk among HIV-infected FSWs in India.

Authors:  Jay G Silverman; Niranjan Saggurti; Debbie M Cheng; Michele R Decker; Sharon M Coleman; Carly Bridden; Manoj Pardeshi; Anindita Dasgupta; Jeffrey H Samet; Anita Raj
Journal:  AIDS Behav       Date:  2014-03

2.  Simulated epidemics in an empirical spatiotemporal network of 50,185 sexual contacts.

Authors:  Luis E C Rocha; Fredrik Liljeros; Petter Holme
Journal:  PLoS Comput Biol       Date:  2011-03-17       Impact factor: 4.475

3.  Globalizing queer? AIDS, homophobia and the politics of sexual identity in India.

Authors:  Subir K Kole
Journal:  Global Health       Date:  2007-07-11       Impact factor: 4.185

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.